Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril

L. Howard Hartley, Greg Flaker, Lofty Basta, Frank Menapace, Steven Goldman, Barry Davis, Peggy Hamm, Gervasio Lamas, Lemuel Moye, Chuan Chuan Wun, Marc Pfeffer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Previous studies after acute myocardial infarction (AMI) have reported conflicting results on the effects of angiotensin-converring enzyme inhibition on physical working capacity. In an effort to provide more insight into this subject, we examined the effects of captopril on working capacity of patients who had low ejection fractions but no congestive heart failure after AMI. One hundred sixty-six participants were recruited from 5 centers after randomization to either captopril or placebo for the Survival and Ventricular Enlargement study. Upright cycle ergometer tests were performed with continuous measurements of respiratory gases at 4, 12, and 24 months after AMI. Our study concurs with 2 of 3 previous post-AMI studies and supports the conclusion that working capacity is not affected by angio-tensin-converring enzyme inhibition at 4 or 12 months after AMI in patients without congestive heart failure. In addition, no significant effect of captopril was noted at 24 months after AMI. Peak oxygen uptake tended to decrease between 12 and 24 months in the placebo group by an average (± SD) of -22 ± 322 ml/min (n = 66), but to increase in the captopril group (+62 ± 289, n = 57), a difference that was significant (Mann-Whitney chi-square, p = 0.02). This post-hoc observation suggests that a late beneficial effect may have been masked by inadequate study duration. Known benefits of captopril appear not to include an increase in working capacity within the first 24 months after AMI.

Original languageEnglish (US)
Pages (from-to)857-860
Number of pages4
JournalThe American journal of cardiology
Volume76
Issue number12
DOIs
StatePublished - Nov 1 1995

Fingerprint

Captopril
Myocardial Infarction
Heart Failure
Placebos
Angiotensins
Enzymes
Random Allocation
Gases
Observation
Oxygen
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril. / Hartley, L. Howard; Flaker, Greg; Basta, Lofty; Menapace, Frank; Goldman, Steven; Davis, Barry; Hamm, Peggy; Lamas, Gervasio; Moye, Lemuel; Wun, Chuan Chuan; Pfeffer, Marc.

In: The American journal of cardiology, Vol. 76, No. 12, 01.11.1995, p. 857-860.

Research output: Contribution to journalArticle

Hartley, LH, Flaker, G, Basta, L, Menapace, F, Goldman, S, Davis, B, Hamm, P, Lamas, G, Moye, L, Wun, CC & Pfeffer, M 1995, 'Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril', The American journal of cardiology, vol. 76, no. 12, pp. 857-860. https://doi.org/10.1016/S0002-9149(99)80249-5
Hartley, L. Howard ; Flaker, Greg ; Basta, Lofty ; Menapace, Frank ; Goldman, Steven ; Davis, Barry ; Hamm, Peggy ; Lamas, Gervasio ; Moye, Lemuel ; Wun, Chuan Chuan ; Pfeffer, Marc. / Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril. In: The American journal of cardiology. 1995 ; Vol. 76, No. 12. pp. 857-860.
@article{fb0eaae680eb41eb8bf7beb4c74ab417,
title = "Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril",
abstract = "Previous studies after acute myocardial infarction (AMI) have reported conflicting results on the effects of angiotensin-converring enzyme inhibition on physical working capacity. In an effort to provide more insight into this subject, we examined the effects of captopril on working capacity of patients who had low ejection fractions but no congestive heart failure after AMI. One hundred sixty-six participants were recruited from 5 centers after randomization to either captopril or placebo for the Survival and Ventricular Enlargement study. Upright cycle ergometer tests were performed with continuous measurements of respiratory gases at 4, 12, and 24 months after AMI. Our study concurs with 2 of 3 previous post-AMI studies and supports the conclusion that working capacity is not affected by angio-tensin-converring enzyme inhibition at 4 or 12 months after AMI in patients without congestive heart failure. In addition, no significant effect of captopril was noted at 24 months after AMI. Peak oxygen uptake tended to decrease between 12 and 24 months in the placebo group by an average (± SD) of -22 ± 322 ml/min (n = 66), but to increase in the captopril group (+62 ± 289, n = 57), a difference that was significant (Mann-Whitney chi-square, p = 0.02). This post-hoc observation suggests that a late beneficial effect may have been masked by inadequate study duration. Known benefits of captopril appear not to include an increase in working capacity within the first 24 months after AMI.",
author = "Hartley, {L. Howard} and Greg Flaker and Lofty Basta and Frank Menapace and Steven Goldman and Barry Davis and Peggy Hamm and Gervasio Lamas and Lemuel Moye and Wun, {Chuan Chuan} and Marc Pfeffer",
year = "1995",
month = "11",
day = "1",
doi = "10.1016/S0002-9149(99)80249-5",
language = "English (US)",
volume = "76",
pages = "857--860",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril

AU - Hartley, L. Howard

AU - Flaker, Greg

AU - Basta, Lofty

AU - Menapace, Frank

AU - Goldman, Steven

AU - Davis, Barry

AU - Hamm, Peggy

AU - Lamas, Gervasio

AU - Moye, Lemuel

AU - Wun, Chuan Chuan

AU - Pfeffer, Marc

PY - 1995/11/1

Y1 - 1995/11/1

N2 - Previous studies after acute myocardial infarction (AMI) have reported conflicting results on the effects of angiotensin-converring enzyme inhibition on physical working capacity. In an effort to provide more insight into this subject, we examined the effects of captopril on working capacity of patients who had low ejection fractions but no congestive heart failure after AMI. One hundred sixty-six participants were recruited from 5 centers after randomization to either captopril or placebo for the Survival and Ventricular Enlargement study. Upright cycle ergometer tests were performed with continuous measurements of respiratory gases at 4, 12, and 24 months after AMI. Our study concurs with 2 of 3 previous post-AMI studies and supports the conclusion that working capacity is not affected by angio-tensin-converring enzyme inhibition at 4 or 12 months after AMI in patients without congestive heart failure. In addition, no significant effect of captopril was noted at 24 months after AMI. Peak oxygen uptake tended to decrease between 12 and 24 months in the placebo group by an average (± SD) of -22 ± 322 ml/min (n = 66), but to increase in the captopril group (+62 ± 289, n = 57), a difference that was significant (Mann-Whitney chi-square, p = 0.02). This post-hoc observation suggests that a late beneficial effect may have been masked by inadequate study duration. Known benefits of captopril appear not to include an increase in working capacity within the first 24 months after AMI.

AB - Previous studies after acute myocardial infarction (AMI) have reported conflicting results on the effects of angiotensin-converring enzyme inhibition on physical working capacity. In an effort to provide more insight into this subject, we examined the effects of captopril on working capacity of patients who had low ejection fractions but no congestive heart failure after AMI. One hundred sixty-six participants were recruited from 5 centers after randomization to either captopril or placebo for the Survival and Ventricular Enlargement study. Upright cycle ergometer tests were performed with continuous measurements of respiratory gases at 4, 12, and 24 months after AMI. Our study concurs with 2 of 3 previous post-AMI studies and supports the conclusion that working capacity is not affected by angio-tensin-converring enzyme inhibition at 4 or 12 months after AMI in patients without congestive heart failure. In addition, no significant effect of captopril was noted at 24 months after AMI. Peak oxygen uptake tended to decrease between 12 and 24 months in the placebo group by an average (± SD) of -22 ± 322 ml/min (n = 66), but to increase in the captopril group (+62 ± 289, n = 57), a difference that was significant (Mann-Whitney chi-square, p = 0.02). This post-hoc observation suggests that a late beneficial effect may have been masked by inadequate study duration. Known benefits of captopril appear not to include an increase in working capacity within the first 24 months after AMI.

UR - http://www.scopus.com/inward/record.url?scp=0028889261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028889261&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(99)80249-5

DO - 10.1016/S0002-9149(99)80249-5

M3 - Article

C2 - 7484820

AN - SCOPUS:0028889261

VL - 76

SP - 857

EP - 860

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12

ER -